tmao l-carnitine γ-Butyrobetaine Is a Proatherogenic Intermediate in Gut Microbial Metabolism of to Trimethylamine N-oxide
Trimethylamine N oxide L Carnitine intake and high trimethylamine N oxide plasma levels correlate with low aortic lesions in ApoE transgenic mice expressing CETP Atherosclerosis Full article: Gut microbes with the gbu genes determine TMAO production from L carnitine intake and serve as a biomarker for precision nutrition Dietary allicin reduces transformation of L carnitine to TMAO through impact on gut microbiota ScienceDirect
Pay in 4 interest-free payments of $5.26 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9



